The results revealed that out of two cohorts, the cohort with PD-L1 TPS (tumor proportion scores) ≥ 50%) (cohort 1) displayed an ORR of 56.3% (95% CI, 29.9–80.2%) [155]. Here, CD274 is linked to neoplasm.